Reactivation of Hepatitis B After Ibalizumab Therapy for Multidrug-Resistant Human Immunodeficiency Virus

Alyson Kaplan1, Elliott DeHaan2, Charles Maltz1

  • 1Division of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell School of Medicine, New York Presbyterian, New York, NY.

ACG Case Reports Journal
|September 22, 2021
PubMed